DOI QR코드

DOI QR Code

Effects of Antioxidant on Reduction of Hindlimb Muscle Atrophy Induced by Cisplatin in Rats

항산화제가 시스플라틴에 의해 유발된 쥐의 뒷다리근 위축 경감에 미치는 영향

  • Kim, Jin Il (Department of Nursing, Christian College of Nursing) ;
  • Choe, Myoung-Ae (College of Nursing, Seoul National University.Oita University of Nursing and Health Sciences)
  • 김진일 (기독간호대학교 간호학과) ;
  • 최명애 (서울대학교 간호대학.오이타현립 간호과학대학)
  • Received : 2014.04.11
  • Accepted : 2014.06.23
  • Published : 2014.08.29

Abstract

Purpose: The purpose of this study was to examine the effects of Cu/Zn SOD on reduction of hindlimb muscular atrophy induced by cisplatin in rats. Methods: Forty-two rats were assigned to three groups; control group, Cisplatin (CDDP) group and cisplatin with Cu/Zn SOD (CDDP-SOD) group. At day 35 hindlimb muscles were dissected. Food intake, activity, withdrawal threshold, muscle weight, and Type I, II fiber cross-sectional area (CSA) of dissected muscles were measured. Relative SOD activity and expression of MHC and phosphorylated Akt, ERK were measured after dissection. Results: Muscle weight and Type I, II fiber CSA of hindlimb muscles in the CDDP group were significantly less than the control group. Muscle weight and Type I, II fiber CSA of hindlimb muscles, food intake, activity, and withdrawal thresholds of the CDDP-SOD group were significantly greater than the CDDP group. There were no significant differences in relative SOD activities of hindlimb muscles between the CDDP-SOD and CDDP groups. MHC expression and phosphorylated Akt, ERK of hindlimb muscles in the CDDP-SOD group were significantly greater than the CDDP group. Conclusion: Cu/Zn SOD attenuates hindlimb muscular atrophy induced by cisplatin through increased food intake and activity. Increment of phosphorylated Akt, ERK may relate to attenuation of hindlimb muscular atrophy.

Keywords

References

  1. Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer: Current status. Cancer Treatment Reviews. 2004;30(1):53-81. http://dx.doi.org/10.1016/s0305-7372(03)00139-7
  2. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins. 2010;2(11):2490-2518. http://dx.doi.org/10.3390/toxins2112490
  3. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Experimental Neurology. 2003;182(1):12-20. https://doi.org/10.1016/S0014-4886(03)00003-7
  4. Yakabi K, Sadakane C, Noguchi M, Ohno S, Ro S, Chinen K, et al. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology. 2010;151(8):3773-3782. http://dx.doi.org/10.1210/en.2010-0061
  5. Gill JS, Windebank AJ. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. The Journal of Clinical Investigation. 1998;101(12):2842-2850. http://dx.doi.org/10.1172/jci1130
  6. Yoo YS, Cho OH. Relationship between quality of life and nurse-led bedside symptom evaluations in patients with chemotherapy-induced peripheral neuropathy. Asian Nursing Research. 2014;8(1):36-41. http://dx.doi.org/10.1016/j.anr.2013.11.002
  7. Yang GS, Choe MA. Effect of anorexia and neuropathic pain induced by cisplatin on hindlimb muscles of rat. Journal of Korean Academy of Nursing. 2013;43(3):361-369. http://dx.doi.org/10.4040/jkan.2013.43.3.361
  8. Powers SK, Smuder AJ, Judge AR. Oxidative stress and disuse muscle atrophy: Cause or consequence? Current Opinion in Clinical Nutrition and Metabolic Care. 2012;15(3):240-245. http://dx.doi.org/10.1097/MCO.0b013e328352b4c2
  9. Vera G, Castillo M, Cabezos PA, Chiarlone A, Martin MI, Gori A, et al. Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterology and Motility. 2011;23(4):370-378. http://dx.doi.org/10.1111/j.1365-2982.2011.01674.x
  10. Kim JI, Choe MA. A comparison between effects of anorexia induced by consecutive low-dose cisplatin and high-dose cisplatin on hindlimb muscles of rats. Journal of Korean Biological Nursing Science. 2012;14 (1):49-56. https://doi.org/10.7586/jkbns.2012.14.1.49
  11. Choe MA, An GJ, Koo BS, Jeon S. Effect of DHEA on recovery of muscle atrophy induced by parkinson's disease. Journal of Korean Academy of Nursing. 2011;41(6):834-842. http://dx.doi.org/10.4040/jkan.2011.41.6.834
  12. Castaneda C. Muscle wasting and protein metabolism. Journal of Animal Science. 2002;80(Suppl 2):E98-E105. https://doi.org/10.2527/animalsci2002.80E-Suppl_2E98x
  13. Hart PJ, Balbirnie MM, Ogihara NL, Nersissian AM, Weiss MS, Valentine JS, et al. A structure-based mechanism for copper-zinc superoxide dismutase. Biochemistry. 1999;38(7):2167-2178. http://dx.doi.org/10.1021/bi982284u
  14. Kim W, Kim DW, Yoo DY, Chung JY, Hwang IK, Won MH, et al. Neuroprotective effects of PEP-1-Cu,Zn-SOD against ischemic neuronal damage in the rabbit spinal cord. Neurochemical Research. 2012;37(2): 307-313. http://dx.doi.org/10.1007/s11064-011-0613-0
  15. Noshita N, Sugawara T, Lewen A, Hayashi T, Chan PH. Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. Stroke. 2003;34(6):1513-1518. http://dx.doi.org/10.1161/01.str.0000072986.46924.f4
  16. Widegren U, Ryder JW, Zierath JR. Mitogen-activated protein kinase signal transduction in skeletal muscle: Effects of exercise and muscle contraction. Acta Physiologica Scandinavica. 2001;172(3):227-238. http://dx.doi.org/10.1046/j.1365-201x.2001.00855.x
  17. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/ Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biology. 2001;3(11):1009-1013. http://dx.doi.org/10.1038/ncb1101-1009
  18. Li G, Feng X, Wang S. Effects of Cu/Zn superoxide dismutase on strain injury-induced oxidative damage to skeletal muscle in rats. Physiological Research. 2005;54(2):193-199.
  19. Mead R. The design of experiments : Statistical principles for practical applications. 9th ed.. Cambridge, UK: Cambridge University Press; 1988. 587.
  20. Baillet F, Housset M, Michelson AM, Puget K. Treatment of radiofibrosis with liposomal superoxide dismutase. Preliminary results of 50 cases. Free Radical Research Communications. 1986;1(6):387-394. https://doi.org/10.3109/10715768609051643
  21. Fanzani A, Zanola A, Rovetta F, Rossi S, Aleo MF. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicology and Applied Pharmacology. 2011;250(3): 312-321. http://dx.doi.org/10.1016/j.taap.2010.11.003
  22. Caso G, Garlick PJ, Ballou LM, Vosswinkel JA, Gelato MC, McNurlan MA. The increase in human muscle protein synthesis induced by food intake is similar when assessed with the constant infusion and flooding techniques. The Journal of Nutrition. 2006;136(6):1504-1510. https://doi.org/10.1093/jn/136.6.1504
  23. Munoz KA, Aannestad A, Tischler ME, Henriksen EJ. Skeletal muscle protein content and synthesis after voluntary running and subsequent unweighting. Metabolism. 1994;43(8):994-999. https://doi.org/10.1016/0026-0495(94)90179-1
  24. Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K. Methods for testing antioxidant activity. The Analyst. 2002;127(1):183-198. https://doi.org/10.1039/b009171p
  25. Tiidus PM, Bombardier E, Hidiroglou N, Madere R. Estrogen administration, postexercise tissue oxidative stress and vitamin C status in male rats. Canadian Journal of Physiology and Pharmacology. 1998;76(10-11):952-960. https://doi.org/10.1139/y98-111
  26. Rush JW, Green HJ, Maclean DA, Code LM. Oxidative stress and nitric oxide synthase in skeletal muscles of rats with post-infarction, compensated chronic heart failure. Acta Physiologica Scandinavica. 2005;185(3):211-218. http://dx.doi.org/10.1111/j.1365-201X.2005.01479.x
  27. Tominaga T, Hachiya M, Shibata T, Sakamoto Y, Taki K, Akashi M. Exogenously- added copper/zinc superoxide dismutase rescues damage of endothelial cells from lethal irradiation. Journal of Clinical Biochemistry and Nutrition. 2012;50(1):78-83. http://dx.doi.org/10.3164/jcbn.11-15
  28. Zhang Y, Davis C, Sakellariou GK, Shi Y, Kayani AC, Pulliam D, et al. CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice. FASEB Journal. 2013;27(9):3536-3548. http://dx.doi.org/10.1096/fj.13-228130
  29. Salganik RI. The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population. Journal of the American College of Nutrition. 2001;20(5 Suppl):464S-472S. https://doi.org/10.1080/07315724.2001.10719185
  30. Akan Z, Garip AI. Antioxidants may protect cancer cells from apoptosis signals and enhance cell viability. Asian Pacific Journal of Cancer Prevention. 2013;14(8):4611-4614. https://doi.org/10.7314/APJCP.2013.14.8.4611

Cited by

  1. 동물 실험을 적용한 국내 간호 연구 동향 분석 vol.17, pp.4, 2014, https://doi.org/10.7586/jkbns.2015.17.4.324